文献速递淋巴瘤

PRDM1 在人 NK 细胞分化与活化中的关键调控作用

Key regulatory roles of PRDM1 in human NK-cell differentiation and activation.
PubMed 文献 · Leukemia · 2025-12-09

该研究采用多组学方法解析转录因子 PRDM1 对人 NK 细胞的转录调控。PRDM1 缺失的 NK 细胞呈现不成熟表型,类似 CD56bright 群体并上调干性基因特征。PRDM1 活性缺失在 NK 细胞恶性肿瘤中常见,可能促进淋巴瘤发生。

要点

  • PRDM1 对人 NK 细胞终末分化重要,缺失导致不成熟表型及干性特征上调。
  • PRDM1 可作转录抑制因子或激活因子,活性受不同转录因子和辅因子影响。
  • PRDM1 活性缺失在 NK 细胞恶性肿瘤中常见,可能促进淋巴瘤发生。

核心结论

  • PRDM1 在人 NK 细胞终末分化与稳态调控中起关键作用,其活性缺失与 NK 细胞恶性肿瘤相关并可能促进淋巴瘤发生。

研究设计与样本

  • 采用多组学方法解析 PRDM1 对人 NK 细胞的转录调控,基于基因表达谱及靶基因分析。

主要发现

  • PRDM1 缺失的 NK 细胞呈现不成熟表型,模拟 CD56bright NK 细胞群体,并上调干性基因特征。
  • PRDM1 结合的基因富集于 T/NK 细胞受体信号、活化及 NK 细胞效应功能。
  • PRDM1 可作转录抑制因子或激活因子,其活性可因与不同转录因子和辅因子结合而改变,且作用动力学因靶基因而异。
  • PRDM1 在 IL-2 和饲养细胞刺激后诱导,但饲养细胞刺激下其限制 NK 细胞生长的能力可能被 AP-1 诱导的转录网络抵消。
  • PRDM1 活性缺失在 NK 细胞恶性肿瘤中常见,可能导致稳态控制减弱、终末分化受损、细胞适应性增强及获得更多干性特征。

临床怎么用

  • 在 NK 细胞恶性肿瘤中应关注 PRDM1 活性缺失,其可能导致稳态失控和分化受损。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PRDM1, encoding a transcription factor (TF), regulates plasma cell and CD8+ T-cell terminal differentiation and Th2 lineage specification, while its role in human NK-cell differentiation and homeostasis is largely unknown. Here, we employed a multi-omics approach to dissect the transcriptional control of PRDM1 on human NK-cells. PRDM1 is important in NK-cell terminal differentiation based on gene expression profiling and its targeting of key regulators in the process. PRDM1-deleted NK-cells displayed a less mature phenotype simulating the CD56bright NK-cell population accompanied by upregulation of stem-like gene signatures. PRDM1-bound genes were enriched in T/NK-cell receptor signaling, activation, and NK-cell effector functions. PRDM1 could function as a transcriptional repressor as well as an activator as its activities may be modified by association with different TFs and co-factors. The kinetics of its action also varies among its target genes. As a homeostatic factor, PRDM1 is induced upon IL-2 and feeder cell stimulation, but its ability to restrict NK-cell growth upon feeder stimulation may be counteracted by the AP-1-induced transcriptional network. The loss of PRDM1 activity is frequent in NK-cell malignancies which may lead to decreased homeostatic control, impaired terminal differentiation, enhanced cellular fitness, and the acquisition of more stem-like features, thereby promoting lymphomagenesis.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Liu X, Shi Y, Zhang J, et al. Key regulatory roles of PRDM1 in human NK-cell differentiation and activation. Leukemia. 2025. PMID: 41366532. doi:10.1038/s41375-025-02815-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。